- Home
- BNZI vs AIMD Comparison
BNZI vs AIMD Comparison
Compare BNZI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- AIMD
- Stock Information
- Founded
- BNZI 2016
- AIMD 1984
- Country
- BNZI United States
- AIMD United States
- Employees
- BNZI N/A
- AIMD N/A
- Industry
- BNZI
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- AIMD Health Care
- Exchange
- BNZI Nasdaq
- AIMD Nasdaq
- Market Cap
- BNZI 11.5M
- AIMD 11.9M
- IPO Year
- BNZI N/A
- AIMD N/A
- Fundamental
- Price
- BNZI $4.90
- AIMD $3.11
- Analyst Decision
- BNZI Strong Buy
- AIMD
- Analyst Count
- BNZI 1
- AIMD 0
- Target Price
- BNZI $24.00
- AIMD N/A
- AVG Volume (30 Days)
- BNZI 4.2M
- AIMD 75.7K
- Earning Date
- BNZI 08-13-2025
- AIMD 08-04-2025
- Dividend Yield
- BNZI N/A
- AIMD N/A
- EPS Growth
- BNZI N/A
- AIMD N/A
- EPS
- BNZI N/A
- AIMD N/A
- Revenue
- BNZI $6,827,490.00
- AIMD $106,207.00
- Revenue This Year
- BNZI $570.18
- AIMD N/A
- Revenue Next Year
- BNZI $34.44
- AIMD N/A
- P/E Ratio
- BNZI N/A
- AIMD N/A
- Revenue Growth
- BNZI 52.95
- AIMD 13.38
- 52 Week Low
- BNZI $0.54
- AIMD $2.00
- 52 Week High
- BNZI $11.20
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- BNZI 29.94
- AIMD 57.16
- Support Level
- BNZI $4.11
- AIMD $3.07
- Resistance Level
- BNZI $6.90
- AIMD $3.34
- Average True Range (ATR)
- BNZI 0.66
- AIMD 0.24
- MACD
- BNZI -0.03
- AIMD 0.07
- Stochastic Oscillator
- BNZI 23.09
- AIMD 79.73
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.